Zimmer Holdings, Inc.
Warsaw , IN
Sector: HEALTHCARE / Medical Appliances & Equipment
Pickett heads the pharmaceutical research arm of Schering-Plough, a healthcare company that produces prescription medications. Pickett, whose 2003 research and development efforts generated $1.47 billion in revenues, had a hand in marketing successful allergy and respiratory drugs like Clarinex, Claritin, and Nasonex. The medications contributed more than $4.2 billion to the company's bottom line when they hit the market. Pickett came to Schering-Plough from Merck Research Laboratories, where he served as senior vice president. He is also a member of the U.S. Food and Drug Administration Science Board. Pickett holds a Ph.D. in cell biology from UCLA and has been published extensively in leading research journals. He has been a frequent speaker at scientific symposiums and conferences.
Cecil B. Pickett, Ph.D., President, Research and Development of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received his B.Sc. in biology from California State University at Hayward and his Ph.D. in cell biology from University of California at Los Angeles. He is also a member of the Institute of Medicine of The National Academy of Sciences. Dr. Pickett previously served as a director of Biogen Idec.
Cecil B. Pickett, Ph.D., President, Research and Development of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received his B.Sc. in biology from California State University at Hayward and his Ph.D. in cell biology from University of California at Los Angeles. He is also a member of the Institute of Medicine of The National Academy of Sciences. Dr. Pickett previously served as a director of Biogen Idec.
